Antipsychotic Agents (administration & dosage) < Antipsychotic Agents (adverse effects) < Antipsychotic Agents (chemistry)

Facettes :

List of bibliographic references indexed by Antipsychotic Agents (adverse effects)

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000055 (2017)	Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil]	Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
000060 (2017)	Karim Selfani [Canada] ; Valérie L. Soland ; Sylvain Chouinard ; Philippe Huot	Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
000630 (2015)	Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput	Neuroleptic‐induced Parkinsonism: Clinicopathological study
000689 (2015)	Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]	Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
001267 (2012)	Pierre J. Blanchet [Canada] ; Louise Normandeau ; Pierre H. Rompré	Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot study.
001280 (2012)	Connie Marras [Canada] ; Nathan Herrmann ; Geoffrey M. Anderson ; Hadas D. Fischer ; Xuesong Wang ; Paula A. Rochon	Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
001597 (2011)	Gary Remington [Canada] ; Ofer Agid ; George Foussias	Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.
001624 (2011)	Jonathan Brotchie [Canada] ; Peter Jenner	New approaches to therapy.
002148 (2008)	Leonardo Cortese [Canada] ; Michael P. Caligiuri ; Richard Williams ; Peter Schieldrop ; Rahul Manchanda ; Ashok Malla ; Raj Harricharan	Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
002690 (2007)	Richard Camicioli [Canada] ; Serge Gauthier [Canada]	Clinical trials in Parkinson's disease dementia and dementia with lewy bodies
002757 (2006)	Kelvin L. Chou [États-Unis] ; Joseph H. Friedman	Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?
002981 (2005)	William G. Honer [Canada] ; Lili C. Kopala ; Jonathan Rabinowitz	Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
002996 (2005)	Paula A. Rochon [Canada] ; Therese A. Stukel ; Kathy Sykora ; Sudeep Gill ; Susan Garfinkel ; Geoffrey M. Anderson ; Sharon-Lise T. Normand ; Muhammad Mamdani ; Philip E. Lee ; Ping Li ; Susan E. Bronskill ; Connie Marras ; Jerry H. Gurwitz	Atypical antipsychotics and parkinsonism.
003118 (2001)	S B Patten [Canada] ; J V Williams ; R. Petcu ; R. Oldfield	Delirium in psychiatric inpatients: a case-control study.
003852 (1998)	S M Mirsattari [Canada] ; C. Power ; A. Nath	Parkinsonism with HIV infection.
003861 (1998)	P. Seeman [Canada] ; R. Corbett ; H H Van Tol	Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
003868 (1998)	P. Seeman [Canada] ; T. Tallerico	Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
003A66 (1997)	L A Tugg [Canada] ; D. Desai ; P. Prendergast ; G. Remington ; K. Reed ; R B Zipursky	Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
004646 (1992)	E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. Bedard	Ethosuximide and tremor in Parkinson's disease : a pilot study
004B43 (1988)	T. Zilker ; F. Fogt ; M. Von Clarmann	[No Parkinsonian syndrome following acute paraquat poisoning].
004B44 (1988)	G. Chouinard [Canada]	The use of benzodiazepines in the treatment of manic-depressive illness.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antipsychotic Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antipsychotic Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antipsychotic Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022